Already a member? Sign in
Lidocaine is a local anesthetic. It works by stopping nerves from sending pain signals. Lidocaine comes as a transdermal patch applied directly to the skin for localized relief of acute hypersensitivity and chronic pain in postherpetic neuralgia.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Pain | 97 | 18 |
|
|
|
|
|
| Back pain | 81 | 16 |
|
|
|
|
|
| Neck pain | 25 | 8 |
|
|
|
||
| Pain in shoulders | 23 | 10 |
|
|
|
||
| Other | 19 | 7 |
|
|
|
||
| Muscle pain | 17 | 3 |
|
|
See all 260 patients currently taking Lidocaine Transdermal
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Lidocaine Transdermal
| Rash or skin problems | 5 | |
|---|---|---|
| Bruising | 1 | |
| Burning sensation in skin | 1 | |
| Elevated blood pressure | 1 | |
| Pain in shoulders | 1 | |
| Neck pain | 1 | |
| See all 14 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Lidocaine Transdermal. See all 56 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 28 | ||
| Course of treatment ended | 11 | ||
| Other | 9 | ||
| Expense | 9 | ||
| Side effects too severe | 3 | ||
| Doctor's advice | 3 | ||
| Change in health plan coverage | 3 | ||
| Not indicated | 1 |
See all 56 patients who’ve stopped taking Lidocaine Transdermal
Adherence
Taking treatment as prescribed
Adherence of Lidocaine Transdermal
Always |
30 | 46% |
|
|---|---|---|---|
Usually |
16 | 25% |
|
Sometimes |
13 | 20% |
|
Never |
6 | 9% |
|
Burden
Difficulty being on treatment
Burden of Lidocaine Transdermal
Very |
7 | 11% |
|
|---|---|---|---|
Somewhat |
8 | 12% |
|
A little |
25 | 38% |
|
Not at all |
25 | 38% |
|
Cost
Paid out of pocket
Cost of Lidocaine Transdermal
$200+ |
5 | 11% |
|
|---|---|---|---|
$100-199 |
4 | 9% |
|
$50-99 |
4 | 9% |
|
$25-49 |
11 | 24% |
|
< $25 |
21 | 47% |
|
Report created on February 12, 2012.